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PYRIBENZAMINE IN EXPERIMENTAL NONALLERGIC
AND ALLERGIC DERMATITIS'
R. L. MAYER2
I. INTE0DUC1I0N
According to the present theories of anaphylaxis, the antigen-antibody reaction
produces, by a still unknown mechanism, a cell injury. In this primary phase
histamine does not seem to be involved; however, if histamine is present in the
injured cell, it is released during this cell irritation. The released histamine is
thus considered, according to the present theories, to be a by-product of the
antigen-antibody reaction. If the organism is sensitive to histamine, the
amounts liberated are high enough to induce toxic symptoms. In this case
only, histamine can be spoken of as the "anaphylactic poison" and held responsi-
ble for the majority of the anaphylactic manifestations (Code (1)).
Much indirect and direct evidence has been accumulated proving that hista-
mine plays an active role not only in certain anaphylactic manifestations (Code
(2), Dragstedt (3), Rose (4)), but also in those of urticaria, hay fever, dermo-
graphia and in cold and light allergy (Rose (4), Kalk (5), Horton et al. (6)). Up
to ten times the normal level has been detected in vitro after the contact of anti-
gen with allergic organs (Schild (7), Farber et al. (8), Cloyd and Selle (9) and
others), and in vivo during allergic attacks.
Contrary to the above-mentioned allergies of the atopic type, our knowledge
of the role of histamine in allergic manifestations of the contact type is very
limited. Systematic histamine determination in the blood of patients suffering
from contact dermatitis or in the diseased skin, have not yet been published;
however, the disappointing clinical results obtained in cases of contact dermatitis
with various antihistaminic substances seems to justify the opinion of those who
maintain that histamine is not directly involved in allergic manifestations of the
epidermal type. This is quite indirect proof. However, since it is generally
supposed that the antihistaminic substances, like Pyribenzamine and others,
specifically counteract pathologic reactions caused by histamine, they are re-
garded by many investigators as reliable biologic reagents for histamine. If a
certain allergic disease is ameliorated or cured by these compounds, it is believed
that histamine plays a determining role in the manifestations of this allergy; and,
conversely, it is believed that histamine can be ruled out as a causative factor in
cases in which these compounds are inactive.
The therapeutic results obtained with antihistaminic substances, such as
Pyribenzamine and others, in various allergies, have varied considerably accord-
ing to the site of the allergic manifestation. With the most active compounds
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